BCA is a regulated-market-access firm anchored on life sciences, with Germany as the EU gateway. We are deliberately small and senior — the people who read your market and carry your local relationships are the people you'll actually work with.
The defensible part of this work isn't a strategy document — it's execution and named human accountability. So the firm has to be nameable.
Our thesis is that authorization isn't the same as getting paid, and that the hard, defensible layer is the relationships and execution that decide revenue. A firm making that claim with no named people behind it would contradict itself. So here we are, in the open: who we are, how we work, and the international reach we bring.
Small, senior and accountable. The person who reads your market is the person in the room when it's negotiated. No anonymous hand-offs.
Replace the placeholders below with real leads, credentials and a one-line track record each — this is the single most important block on the page.
15 years in German pharma. A former product manager who has worked across the full regulatory landscape — G-BA, IQWiG, BfArM and the relevant authorities — and repeatedly built and led cross-functional project groups from dossier to launch.
Languages: German · English · French
7 years in pharma consulting and market entry, with launches and partner networks built across Austria, France, Canada, Korea and Germany. Leads discovery, partner and distributor search, and the commercial relationships that carry a launch on the ground.
Languages: English · German · Spanish
Being honest about the boundary is part of being credible. We own the commercial and relationship layer; we coordinate the specialists around it.
Our international presence gives entrants a credible EU footprint beyond Germany — and gives German companies a partner network for going out. Germany first; the EU from there, in both directions.
We work with international companies entering Germany and the EU — drawing on hands-on market experience across Korea, Canada, France, Austria and Germany — and with German organizations taking products and equipment to markets abroad.
The through-line is the same either way: regulated, technically complex sectors where the entry barrier is real and a local guide is not optional.
Specialist partners you coordinate (regulatory, pharmacovigilance, Notified Body, data-security), any association memberships, and 2–3 anonymized cases (origin country, product class, outcome, rough timeline). These convert interest into trust.
Start with a focused, low-risk session — you'll meet the lead who would run your engagement.
Book a session →